title: [Evaluation of the enhanced International Prognostic Index (NCCN-IPI) for cases with diffuse large B-cell lymphoma].
abstract: The NCCN-International Prognostic Index (IPI) is reported to be more powerful than the former IPI for predicting survival in the rituximab era. To evaluate the NCCN-IPI in our institutions, we analyzed 188 patients with diffuse large B-cell lymphoma treated with rituximab plus CHOP or THP-COP chemotherapy. The 5-year overall survival rates of patients with low, low-intermediate, high-intermediate, and high risk were 90%, 76%, 64%, and 34%, respectively. Although there was no difference in overall survival between patients 61-75 and those >75 years of age, the NCCN-IPI is useful for classifying prognostically relevant subgroups of Japanese patients.
authors.affiliation: Division of Hematology, Department of Medicine, Nippon Medical School.
authors.forename: Akiko
authors.initials: A
authors.lastname: Yamada
authors.forename: Hideto
authors.initials: H
authors.lastname: Tamura
authors.forename: Toshio
authors.initials: T
authors.lastname: Asayama
authors.forename: Keiichi
authors.initials: K
authors.lastname: Moriya
authors.forename: Namiko
authors.initials: N
authors.lastname: Okuyama
authors.forename: Asaka
authors.initials: A
authors.lastname: Kondo-Onodera
authors.forename: Yasuko
authors.initials: Y
authors.lastname: Hamada
authors.forename: Mariko
authors.initials: M
authors.lastname: Ishibashi
authors.forename: Norio
authors.initials: N
authors.lastname: Yokose
authors.forename: Sakae
authors.initials: S
authors.lastname: Tanosaki
authors.forename: Koiti
authors.initials: K
authors.lastname: Inokuchi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D055815:Young Adult